FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1155971003: Dacomitinib monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4571023013 Dacomitinib monohydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4571024019 Dacomitinib monohydrate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dacomitinib monohydrate Is a Quinazoline true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Is a Piperidine true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Is modification of Dacomitinib true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Dacomitinib monohydrate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vizimpro 45mg tablets (Pfizer Ltd) Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Vizimpro 15mg tablets (Pfizer Ltd) Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Vizimpro 45mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Vizimpro 15mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 45mg tablets 30 tablet Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 45mg tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 30mg tablets 30 tablet Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 30mg tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets Has specific active ingredient True Dacomitinib monohydrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start